Risk factors for pulmonary embolism in chronic dialysis patients

Journal of Nephrology

Volumn 15, Issue 3, 2002, Pages 241-247

  Tveit, Daniel P ^a   Hshieh, Paul ^a   Cruess, David ^a   Agodoa, Lawrence Y C ^a   Welch, Paul G ^a   Abbott, Kevin C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Age; Albumin; CHF; Complications; Dialysis; Female; Hemodialysis; Peritoneal dialysis; Polycystic kidney disease; Pulmonary embolism; USRDS

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASIAN; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIALYSIS; ETHNIC DIFFERENCE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL MODEL; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; CHRONIC KIDNEY FAILURE; MIDDLE AGED; REGISTER; RENAL REPLACEMENT THERAPY; STATISTICS; TIME;

ADULT; COHORT STUDIES; FEMALE; HUMAN; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; PULMONARY EMBOLISM; REGISTRIES; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS; UNITED STATES; HUMANS; MIDDLE AGED;

EID: 0035985346     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. The "primary" antiphospholipid syndrome: Major clinical and serological features
2. Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted?
3. Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States
4. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
5. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
6. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry
7. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study
8. Etiology of bacterial septicemia in chronic dialysis patients in the United States
9. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: Patient characteristics and survival in the pre highly active antiretroviral therapy era
10. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans
11. Decreasing mortality from pulmonary embolism in the United States, 1979-1996
12. Risk factors in pulmonary embolism
13. Risk factor assessment in 101 total hip arthroplasties: A medical perspective
14. A prospective study of risk factors for pulmonary embolism in women
15. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus
16. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%
17. Chronic dialysis patients are at high risk of pulmonary embolism
18. Hypercoagulability in dialysis patients: Fact or fiction?
19. The microinflammatory state in uremia: Causes and potential consequences
20. Deep vein thrombosis in end-stage renal disease
21. Pulmonary embolism. Low incidence in chronic renal failure
22. Activated protein C (APC). Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states
23. Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: Relationship with systemic inflammation and haemostatic activation
24. The activity of t-PA is markedly decreased in chronic renal failure
25. Hemostasis, platelet function and serotonin in acute and chronic renal failure
26. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis
27. Hemostatic disorder of uremia: The platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis
28. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis
29. Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor
30. Thrombophilic factors in chronic thromboembolic pulmonary hypertension
31. Thrombosis and hemostasis in renal disease
32. Venous thromboembolism epidemiology: Implications for prevention and management
33. Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology
34. Hormone replacement therapy with estradiol and risk of venous thromboembolism - A population-based case-control study
35. Body mass index as a predictor of continued survival in older chronic dialysis patients
36. Obesity at presentation to end stage renal disease in the United States: Patient characteristics and survival
37. Compression of the inferior vena cava by right renal cysts: An unusual cause of IVC and/or iliofemoral thrombosis with pulmonary embolism in autosomal polycystic kidney disease
38. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD
39. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States
40. Septicemia in diabetic hemodialysis patients: Comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients
41. Factor V Leiden mutation: Potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis
42. Antiphospholipid antibody syndrome and renal disease